Prognostic impact of myosteatosis in patients with colorectal cancer undergoing curative surgery: an updated systematic review and meta-analysis
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: Colorectal cancer (CRC) is a global health concern, and identifying prognostic factors can improve outcomes. Myosteatosis is fat infiltration into muscles and is a potential predictor of the survival of patients with CRC. Methods: This systematic review and meta-analysis aimed to assess the prognostic role of myosteatosis in CRC. PubMed, Embase, and Cochrane CENTRAL were searched up to 1 August 2023, for relevant studies, using combinations of the keywords CRC, myosteatosis, skeletal muscle fat infiltration, and low skeletal muscle radiodensity. Case–control, prospective, and retrospective cohort studies examining the association between myosteatosis and CRC outcomes after curative intent surgery were eligible for inclusion. Primary outcomes were overall survival (OS), disease-free survival (DFS), and cancer-specific survival (CSS). Results: A total of 10 studies with a total of 9,203 patients were included. The pooled hazard ratio (HR) for OS (myosteatosis vs. no myosteatosis) was 1.52 [95% confidence interval (CI), 1.38–1.67); for CSS, 1.67 (95% CI, 1.40–1.99); and for DFS, 1.89 (95% CI, 1.35–2.65). Conclusion: In patients with CRC undergoing curative intent surgery, myosteatosis is associated with worse OS, CSS, and DFS. These findings underscore the importance of evaluating myosteatosis in patients with CRC to improve outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“reduced muscle radiodensity (myosteatosis) carries additional adverse prognostic weight [11,12,13]”
In the citing paper
“Myosteatosis has been linked to mortality independently of muscle mass in CRC and other solid tumors [12,13,41]”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Hossain, M. S., Karuniawati, H., Jairoun, A. A., Urbi, Z., Ooi, D. J., John, A., Lim, Y. C., Kibria, K. M. K., Mohiuddin, A. K. M., Ming, L. C., et al. (2022) · Cancers · doi:10.3390/cancers14071732 · Cited by 920 · cited 1×
“In 2020, CRC accounted for approximately 9.4% of all cancer-related fatalities (3).”
BackgroundInfluentialCorrea-de-Araujo, R., Addison, O., Miljkovic, I., Goodpaster, B. H., Bergman, B. C., Clark, R. V., Elena, J. W., Esser, K. A., Ferrucci, L., Harris-Love, M. O., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00963 · Cited by 468
Research works printed but not linked: 34
- Rawla, 2019, Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors, Prz Gastroenterol, 14, 89, 10.5114/pg.2018.81072 · DOI · Paper page
- Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 71, 10.3322/caac.21660 · DOI · Paper page
- Aleixo, 2020, Myosteatosis and prognosis in cancer: Systematic review and meta-analysis, Crit Rev Oncol Hematol, 145, 102839, 10.1016/j.critrevonc.2019.102839 · DOI · Paper page
- Ahn, 2021, Updated systematic review and meta-analysis on diagnostic issues and the prognostic impact of myosteatosis: A new paradigm beyond sarcopenia, Ageing Res Rev, 70, 101398, 10.1016/j.arr.2021.101398 · DOI · Paper page
- Findlay, 2020, Sarcopenia and myosteatosis in patients undergoing curative radiotherapy for head and neck cancer: Impact on survival, treatment completion, hospital admission and cost, J Hum Nutr Diet, 33, 10.1111/jhn.12788 · DOI
- Martin, 2020, Cancer-associated malnutrition and CT-defined sarcopenia and myosteatosis are endemic in overweight and obese patients, JPEN J Parenter Enteral Nutr, 44, 10.1002/jpen.1597 · DOI · Paper page
- Cao, 2022, The prognostic impact of myosteatosis on overall survival in gynecological cancer patients: A meta-analysis and trial sequential analysis, Int J Cancer, 151, 1997, 10.1002/ijc.34179 · DOI
- Feng, 2022, Prognostic value of myosteatosis in patients with lung cancer: a systematic review and meta-analysis, Int J Clin Oncol, 27, 10.1007/s10147-022-02181-1 · DOI
- Pozios, 2022, Impact of myopenia and myosteatosis on postoperative outcome and recurrence in Crohn's disease, Int J Colorectal Dis, 37, 791, 10.1007/s00384-022-04104-y · DOI
- Okugawa, 2022, Clinical relevance of myopenia and myosteatosis in colorectal cancer, J Clin Med, 11, 2, 10.3390/jcm11092617 · DOI
- Lee, 2020, Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta-analysis, J Cachexia Sarcopenia Muscle, 11, 10.1002/jcsm.12575 · DOI · Paper page
- Kroenke, 2018, Muscle radiodensity and mortality in patients with colorectal cancer, Cancer, 124, 10.1002/cncr.31405 · DOI · Paper page
- Sueda, 2018, Impact of low muscularity and myosteatosis on long-term outcome after curative colorectal cancer surgery: A propensity score-matched analysis, Dis Colon Rectum, 61, 10.1097/DCR.0000000000000958 · DOI
- van Baar, 2018, Low radiographic muscle density is associated with lower overall and disease-free survival in early-stage colorectal cancer patients, J Cancer Res Clin Oncol, 144, 10.1007/s00432-018-2736-z · DOI
- van Vugt, 2018, Impact of low skeletal muscle mass and density on short and long-term outcome after resection of stage I-III colorectal cancer, Eur J Surg Oncol, 44, 10.1016/j.ejso.2018.05.029 · DOI
- Hopkins, 2019, The impact of muscle and adipose tissue on long-term survival in patients with stage I to III colorectal cancer, Dis Colon Rectum, 62, 10.1097/DCR.0000000000001352 · DOI
- Aro, 2020, The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients - A retrospective register study, Eur J Surg Oncol, 46, 10.1016/j.ejso.2020.03.206 · DOI
- Park, 2021, Skeletal muscle gauge as a prognostic factor in patients with colorectal cancer, Cancer Med, 10, 10.1002/cam4.4354 · doi:10.1002/cam4.4354
- Aro, 2022, Sarcopenia and myosteatosis are associated with neutrophil to lymphocyte ratio but not glasgow prognostic score in colorectal cancer patients, J Clin Med, 11, 3, 10.3390/jcm11092656 · DOI
- Chen, 2022, Prognostic value of myosteatosis and sarcopenia for elderly patients with colorectal cancer: A large-scale double-center study, Surgery, 172, 10.1016/j.surg.2022.05.031 · DOI
- Koh, 2022, Association of albumin-bilirubin grade and myosteatosis with its prognostic significance for patients with colorectal cancer, Ann Surg Oncol, 29, 10.1245/s10434-022-11445-z · DOI
- Higgins, 2023, Cochrane Handbook for Systematic Reviews of Interventions version 6.4
- Miljkovic, 2021, Computed tomography-derived myosteatosis and metabolic disorders, Diabetes Metab J, 45, 10.4093/dmj.2020.0277 · DOI
- O'Brien, 2022, Impact of myopenia and myosteatosis in patients undergoing abdominal surgery for chronic pancreatitis, Surgery, 172, 10.1016/j.surg.2022.01.021 · DOI
- Ebadi, 2022, Skeletal muscle pathological fat infiltration (Myosteatosis) is associated with higher mortality in patients with cirrhosis, Cells, 11, 4, 10.3390/cells11081345 · DOI
- Czigany, 2020, Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation, Am J Transplant, 20, 493, 10.1111/ajt.15577 · DOI
- Nachit, 2023, AI-based CT body composition identifies myosteatosis as key mortality predictor in asymptomatic adults, Radiology, 307, 10.1148/radiol.222008 · DOI
- Murnane, 2021, Myosteatosis predicts higher complications and reduced overall survival following radical oesophageal and gastric cancer surgery, Eur J Surg Oncol, 47, 10.1016/j.ejso.2021.02.008 · DOI
- Wang, 2021, Myosteatosis reduces overall survival in patients with digestive system Malignancies: a meta-analysis with trial sequential analysis, Nutr Res, 94, 25, 10.1016/j.nutres.2021.08.003 · DOI
- Fang, 2023, Prognostic values of myosteatosis for overall survival in patients with gastric cancers: A meta-analysis with trial sequential analysis, Nutrition, 105, 111866, 10.1016/j.nut.2022.111866 · DOI
- MacCormick, 2023, The impact of myosteatosis on outcomes following surgery for gastrointestinal Malignancy: a meta-analysis, Ann R Coll Surg Engl, 105, 10.1308/rcsann.2021.0290 · DOI
- Cho, 2022, A review of sarcopenia pathophysiology, diagnosis, treatment and future direction, J Korean Med Sci, 37, 10.3346/jkms.2022.37.e146 · DOI · Paper page
- Trejo-Avila, 2021, Sarcopenia predicts worse postoperative outcomes and decreased survival rates in patients with colorectal cancer: a systematic review and meta-analysis, Int J Colorectal Dis, 36, 10.1007/s00384-021-03839-4 · DOI · Paper page
- Franco Valle, 2022, Computed tomography assessment of sarcopenic myosteatosis for predicting overall survival in colorectal carcinoma: systematic review, J Comput Assist Tomogr, 46, 10.1097/RCT.0000000000001281 · DOI
Cited by
Wang, D., Sui, J., Chen, J., Chen, L., Yang, Q., Wang, Y., & Lin, S. (2026) · Healthcare · doi:10.3390/healthcare14172846
Metadata
- Authors
- Chang, Y.-Y., & Cheng, B.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2024-06-19
- Volume
- 14
- ISSN
- 2234-943X
- Cited by
- 21
- References
- 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prognostic impact of myosteatosis in patients with colorectal cancer undergoing curative surgery: an updated systematic review and meta-analysis. https://app.cochat.ai/papers/10.3389/fonc.2024.1388001
- The paper
- Chang, Y.-Y., & Cheng, B. (2024). Prognostic impact of myosteatosis in patients with colorectal cancer undergoing curative surgery: an updated systematic review and meta-analysis. Frontiers in Oncology. https://doi.org/10.3389/fonc.2024.1388001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.